Dipeptidyl peptidase-4 inhibitors, pancreatic cancer and acute pancreatitis: A meta-analysis with trial sequential analysis

The use of dipeptidyl peptidase-4 (DPP-4) inhibitors may be associated with pancreatic cancer and acute pancreatitis. Recent meta-analyses have reported conflicting findings. Therefore, we performed a meta-analysis to assess the risk of both pancreatic cancer and acute pancreatitis associated with t...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinto, Lana C., Rados, Dimitris V., Barkan, Sabrina S., Leitão, Cristiane B., Gross, Jorge L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768864/
https://www.ncbi.nlm.nih.gov/pubmed/29335646
http://dx.doi.org/10.1038/s41598-017-19055-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768864/
https://www.ncbi.nlm.nih.gov/pubmed/29335646
http://dx.doi.org/10.1038/s41598-017-19055-6

Ejemplares similares